. Author manuscript; available in PMC: 2013 May 1.

Published in final edited form as: J Allergy Clin Immunol. 2012 Feb 11;129(5):1243–1251. doi: 10.1016/j.jaci.2012.01.044

Table I.

Patient Characteristics^*

Characteristic	Normal control		Asthmatics
Characteristic	Adults	Children	Adults	Children
Age, years	31 (24–39)	12 (10–15)	32.5 (22–46)	10 (8.5–13)
Gender, M/F	24/27	29/22	17/33	25/28
Patient race, caucasian/other/african-american	15/20/16	4/25/22	18/13/19	9/18/26
BMI, kg/m²	27.8 (24.7–30.7)	20.9 (18.4–24.2)	29 (23.4–34.5)	20 (16.6–24.2)
IgE, kU/ml	58 (25–148)	60 (24–182)	122 (48–422)	226 (89–423)
FEV₁%	100 (88–109)	101 (90–112)	88 (76–97)	93 (77–105)
FEV₁/FVC	82 (77–84)	85 (81–88)	74 (69–81)	82 (72–88)
Patients on ICS, Y/N			32/18	41/12
ICS dose, μg/day			320 (228–500)	360 (180–500)

Values in the table are listed as median (IQR range).